Skip to main content

Chembio Diagnostics, Inc. (CEMI)

NASDAQ: CEMI · IEX Real-Time Price · USD
2.44 0.01 (0.21%)
Oct 21, 2021 3:48 PM EDT - Market open
Market Cap68.94M
Revenue (ttm)35.69M
Net Income (ttm)-26.24M
Shares Out20.22M
EPS (ttm)-1.30
PE Ration/a
Forward PE6.72
Dividendn/a
Ex-Dividend Daten/a
Volume675,502
Open2.41
Previous Close2.43
Day's Range2.40 - 2.47
52-Week Range2.06 - 8.75
Beta1.89
AnalystsBuy
Price Target8.00 (+228.5%)
Est. Earnings DateNov 4, 2021

About CEMI

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private...

IndustryHealth Care Equipment & Supplies
IPO DateOct 18, 2000
Employees355
Stock ExchangeNASDAQ
Ticker SymbolCEMI
Full Company Profile

Financial Performance

In 2020, CEMI's revenue was $32.47 million, a decrease of -5.79% compared to the previous year's $34.46 million. Losses were -$25.52 million, 86.6% more than in 2019.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for CEMI stock is "Buy." The 12-month stock price forecast is 8.00, which is an increase of 228.54% from the latest price.

Price Target
$8.00
(228.54% upside)
Analyst Consensus: Buy

News

Chembio Announces EUA Submission for DPP Respiratory Antigen Panel

Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2 Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2

4 weeks ago - GlobeNewsWire

Investing in Penny Stocks in September? 3 Strategies to Know

Trading penny stocks in September? You need to know these 3 things The post Investing in Penny Stocks in September?

Other symbols:ANYXELA
1 month ago - PennyStocks

Hot Penny Stocks to Buy This Month? 3 to Watch Now

Which penny stocks are on your watchlist for next month? The post Hot Penny Stocks to Buy This Month?

Other symbols:BBIGCEI
1 month ago - PennyStocks

Why Chembio Diagnostics Shares Are Trading Higher Today

Chembio Diagnostics Inc (NASDAQ: CEMI) is trading higher Friday after the company announced its launch of commercial distribution of SCOV-2 Ag Detect Rapid Test, a third party COVID-19 antigen assay. Ch...

1 month ago - Benzinga

Chembio Starts Distribution of Third-Party COVID-19 Antigen Assay

Chembio Diagnostics Inc (NASDAQ: CEMI) has launched the commercial distribution of an FDA-Emergency Use Authorized rapid point-of-care COVID-19 antigen test.  Product inventory is on-hand and immediatel...

1 month ago - Benzinga

Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay

HAUPPAUGE, N.Y., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its launch of com...

1 month ago - GlobeNewsWire

Implied Volatility Surging for Chembio Diagnostics (CEMI) Stock Options

Investors need to pay close attention to Chembio Diagnostics (CEMI) stock based on the movements in the options market lately.

2 months ago - Zacks Investment Research

Chembio Diagnostics Stock Falls As Q2 Earnings Lag Consensus, Doubt On Ability To Continue As Going Concern

Chembio Diagnostics Inc's (NASDAQ: CEMI) Q2 sales increased 26% Y/Y to $6.5 million, missing the consensus of $8.5 million. Net product sales increased 4% to $3.9 million.

2 months ago - Benzinga

Find Cheap Stocks Under $10 to Buy in August

August appears to be a solid time to consider adding stocks. Today we looked at how to screen for highly-ranked stocks trading for under $10 a share.

Other symbols:LXSIRI
2 months ago - Zacks Investment Research

Biotech Penny Stocks Are Heating Up, Here's 3 To Watch Right Now

Why investors are watching these 3 biotech penny stocks right now The post Biotech Penny Stocks Are Heating Up, Here's 3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other symbols:XBIO
2 months ago - PennyStocks

Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021

HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will rele...

2 months ago - GlobeNewsWire

Chembio Diagnostics Pops And Drops: A Technical Look

Chembio Diagnostics Inc. (NASDAQ:CEMI) shares rallied higher Thursday after the company received a $4 million HIV test purchase order from the Partnership for Supply Chain Management, supported by the G...

2 months ago - Benzinga

Chembio To Ship $4M Of WHO-Qualified HIV Test Kits To Ethiopia In 2022

Chembio Diagnostics Inc (NASDAQ: CEMI) has received a $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), supported by The Global Fund. The order comes to purchase Chembi...

2 months ago - Benzinga

Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund

HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $...

2 months ago - GlobeNewsWire

Why Chembio Diagnostics Shares Are Trading Higher Today

Chembio Diagnostics (NASDAQ:CEMI) shares are trading higher after the company announced it received a $28.3 million purchase order from Bio-Manguinhos for its DPP SARS-CoV-2 antigen tests in Brazil. “We...

3 months ago - Benzinga

CEMI Stock: $28M Covid Test Order Sends Chembio Diagnostics Skyrocketing

CEMI stock is soaring after inking its first multi-million dollar sales contract for its FDA-approved Covid-19 rapid antigen test. The post CEMI Stock: $28M Covid Test Order Sends Chembio Diagnostics Sk...

3 months ago - InvestorPlace

Best Penny Stocks To Buy Now? Analysts See 85%-288% Upside In 3

Penny stocks to buy according to Wall Street analysts. But are they worth the risk?

Other symbols:HUTUUUU
3 months ago - PennyStocks

Chembio Stock More Than Doubles On $28M Purchase Order For Its COVID Antigen Tests

Chembio Diagnostics Inc (NASDAQ: CEMI) received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.  The Antigen test...

3 months ago - Benzinga

Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil

HAUPPAUGE, N.Y., July 20, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $...

3 months ago - GlobeNewsWire

Chembio Diagnostics Reports First Quarter 2021 Financial Results

HAUPPAUGE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results f...

5 months ago - GlobeNewsWire

Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021

HAUPPAUGE, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will rel...

5 months ago - GlobeNewsWire

CEMI Stock: One Huge Reason Chembio Is Rocketing Higher Today

CEMI stock is soaring today after the company announced the commercial launch of a rapid Covid-19 test that was met with significant optimism. The post CEMI Stock: One Huge Reason Chembio Is Rocketing H...

6 months ago - InvestorPlace

Why NNOX Stock And CEMI Stock Are Skyrocketing Today

Chembio Diagnostics Inc (NASDAQ: CEMI) shares are trading higher by 41% in Monday's pre-market session after the company announced the commercial launch of a test to differentiate between COVID-19 and t...

Other symbols:NNOX
6 months ago - Benzinga

Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu

In-licensed Rapid Point-of-Care Test Available for Use in Detecting COVID-19 Antigens, Flu A and Flu B from a Single Patient Sample in 15 Minutes In-licensed Rapid Point-of-Care Test Available for Use i...

6 months ago - GlobeNewsWire

Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results

HAUPPAUGE, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results...

7 months ago - GlobeNewsWire